Clinical Trial Update: Four Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Pediatric Subjects [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating a topical gel for treating common warts in pediatric patients completed its four-week safety and efficacy assessment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Verruca Vulgaris

Drugs mentioned

• Topical gel for common warts (undisclosed formulation)

Snippet

Sponsor: Graceway Pharmaceuticals, LLC | Conditions: Warts | Phase 2 | Status: COMPLETED